PPARA and polycystic ovary syndrome: In the context of PPARα expression, Morsy et al. treated PCOS-induced rats with the PPARα agonist fenofibrate which significantly increased superoxide dismutase activity, but decreased body weight, as well as serum testosterone, insulin, anti-Mullerian hormone, and ovarian malondialdehyde levels [42].